Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The diagnosis and management of primary autoimmune haemolytic anaemia
Quentin A. Hill, R. Stamps, Edwin Massey, et al.
British Journal of Haematology (2016) Vol. 176, Iss. 3, pp. 395-411
Open Access | Times Cited: 215

Showing 1-25 of 215 citing articles:

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, et al.
Blood Reviews (2019) Vol. 41, pp. 100648-100648
Open Access | Times Cited: 399
Novel insights into the treatment of complement-mediated hemolytic anemias
Sigbjørn Berentsen, Anita Hill, Quentin A. Hill, et al.
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 161
ACVIM consensus statement on the diagnosis of immune‐mediated hemolytic anemia in dogs and cats
Oliver A. Garden, Linda Kidd, Angela M. Mexas, et al.
Journal of Veterinary Internal Medicine (2019) Vol. 33, Iss. 2, pp. 313-334
Open Access | Times Cited: 146
Autoimmune Hemolytic Anemias
Sigbjørn Berentsen, Wilma Barcellini
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1407-1419
Closed Access | Times Cited: 140
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood (2022) Vol. 140, Iss. 9, pp. 980-991
Open Access | Times Cited: 73
Autoimmune hemolytic anemia
Anita Hill, Quentin A. Hill
Hematology (2018) Vol. 2018, Iss. 1, pp. 382-389
Open Access | Times Cited: 135
Guidelines on the management of drug‐induced immune and secondary autoimmune, haemolytic anaemia
Quentin A. Hill, R. Stamps, Edwin Massey, et al.
British Journal of Haematology (2017) Vol. 177, Iss. 2, pp. 208-220
Open Access | Times Cited: 129
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Blood (2020) Vol. 136, Iss. 4, pp. 480-488
Open Access | Times Cited: 123
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 120
Warm Autoimmune Hemolytic Anemia
Robert A. Brodsky
New England Journal of Medicine (2019) Vol. 381, Iss. 7, pp. 647-654
Closed Access | Times Cited: 115
ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs
James W. Swann, Oliver A. Garden, Claire L. Fellman, et al.
Journal of Veterinary Internal Medicine (2019) Vol. 33, Iss. 3, pp. 1141-1172
Open Access | Times Cited: 100
How I manage patients with cold agglutinin disease
Sigbjørn Berentsen
British Journal of Haematology (2018) Vol. 181, Iss. 3, pp. 320-330
Open Access | Times Cited: 98
Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment
Quentin A. Hill, Anita Hill, Sigbjørn Berentsen
Blood Advances (2019) Vol. 3, Iss. 12, pp. 1897-1906
Open Access | Times Cited: 98
How I treat cold agglutinin disease
Sigbjørn Berentsen
Blood (2021) Vol. 137, Iss. 10, pp. 1295-1303
Open Access | Times Cited: 93
How I treat warm autoimmune hemolytic anemia
Wilma Barcellini, Bruno Fattizzo
Blood (2021) Vol. 137, Iss. 10, pp. 1283-1294
Open Access | Times Cited: 92
Evans’ Syndrome: From Diagnosis to Treatment
S. Audia, N. Grienay, Morgane Mounier, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3851-3851
Open Access | Times Cited: 90
Autoimmune hemolytic anemia: current knowledge and perspectives
Sylwia Sulimiera Michalak, Anna Olewicz‐Gawlik, Joanna Rupa‐Matysek, et al.
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 88
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
Wilma Barcellini, Anna Zaninoni, Juri Alessandro Giannotta, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3859-3859
Open Access | Times Cited: 85
The diagnostic protocol for hereditary spherocytosis‐2021 update
Yangyang Wu, Lin Liao, Faquan Lin
Journal of Clinical Laboratory Analysis (2021) Vol. 35, Iss. 12
Open Access | Times Cited: 58
Anemia in the pediatric patient
Patrick G. Gallagher
Blood (2022) Vol. 140, Iss. 6, pp. 571-593
Open Access | Times Cited: 56
Bruton’s Kinase Inhibitors for the Treatment of Immunological Diseases: Current Status and Perspectives
Ewa Robak, Tadeusz Robak
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2807-2807
Open Access | Times Cited: 47
The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
Sigbjørn Berentsen, Bruno Fattizzo, Wilma Barcellini
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors
Rebecca Karp Leaf, Christopher Ferreri, Deepa Rangachari, et al.
American Journal of Hematology (2019) Vol. 94, Iss. 5, pp. 563-574
Open Access | Times Cited: 61
Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease
Sigbjørn Berentsen
Seminars in Hematology (2018) Vol. 55, Iss. 3, pp. 141-149
Closed Access | Times Cited: 60
<p>Cold agglutinin disease: current challenges and future prospects</p>
Sigbjørn Berentsen, Alexander Röth, Ulla Randen, et al.
Journal of Blood Medicine (2019) Vol. Volume 10, pp. 93-103
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top